ICDD creates diagnostic products and services to advance faster in the development of safe and effective drugs and personalized medicine in order to help patients get the best care possible. ICDD is a science-based company with activities focused on predictive toxicology and drug efficacy, as well as on diagnostics for CNS diseases (neurodegeneration). ICDD has developed proprietary technologies and innovative in vitro models used by our clients & partners to select the most efficient active compound in fee for service or industrial partnership contracts. ICDD’s scientists are long standing & recognized experts in studying the mitochondrial function, in dynamical system biology, and in proteomics. We also operate screening models using cellular signatures for neurodegeneration in Huntington’s and Alzheimer’s diseases to help select and develop disease modyfing drugs. ICDD’s services can be used to better anticipate drug-induced adverse reactions or to ensure proper selection of mitochondria-targeting agents in cancer, cardiovascular, metabolic and CNS diseases. ICDD has also developed models to use its unique technologies to help the cosmetic industry test the safety of their products and substantiate commercial allegations for anti-aging, anti-oxidation, sun-protection, energizing, and firmness.